Literature DB >> 16556075

FOXO factors: a matter of life and death.

Haojie Huang1, Donald J Tindall.   

Abstract

Forkhead box O-class (FOXO) transcription factors, including FOXO1, FOXO3a and FOXO4, function as tumor-suppressor proteins by inhibiting cell proliferation, promoting apoptotic cell death and protecting cells from DNA damage and oxidative stress. The potency of these functions is regulated tightly by phosphorylation, acetylation and ubiquitination. Emerging evidence indicates that protein levels of FOXO1 are under dual regulation by Ak-mediated phosphorylation and Skp2-mediated ubiquitination. Given that Akt and Skp2 proteins are highly activated in human cancers due to the loss of phosphatase and tensin homolog (PTEN), deregulation of the FOXO1 protein appears to be a promising target for future drug discovery and cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16556075     DOI: 10.2217/14796694.2.1.83

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  42 in total

1.  Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism.

Authors:  Gabriel Frampton; Pietro Invernizzi; Francesca Bernuzzi; Hae Yong Pae; Matthew Quinn; Darijana Horvat; Cheryl Galindo; Li Huang; Matthew McMillin; Brandon Cooper; Lorenza Rimassa; Sharon DeMorrow
Journal:  Gut       Date:  2011-11-07       Impact factor: 23.059

2.  Screening of differently expressed genes in human prostate cancer cell lines with different metastasis potentials.

Authors:  Anping Song; Guoning Liao; Mingfu Wu; Yunping Lu; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-10

3.  Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1.

Authors:  Emily Berry; Jennifer L Hardt; Jon Clardy; John R Lurain; J Julie Kim
Journal:  Gynecol Oncol       Date:  2008-11-28       Impact factor: 5.482

4.  Crystallization and preliminary X-ray analysis of a complex of the FOXO1 and Ets1 DNA-binding domains and DNA.

Authors:  Wing W Choy; Drishadwatti Datta; Catherine A Geiger; Gabriel Birrane; Marianne A Grant
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2013-12-24       Impact factor: 1.056

Review 5.  Preclinical studies on histone deacetylase inhibitors as therapeutic reagents for endometrial and ovarian cancers.

Authors:  Brahma N Singh; Hongyuan Zhou; Jinping Li; Tracy Tipton; Bin Wang; Guo Shao; E Nickolas Gilbert; Qiang Li; Shi-Wen Jiang
Journal:  Future Oncol       Date:  2011-12       Impact factor: 3.404

6.  Altered FOXO1 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients.

Authors:  Chia-Chen Kuo; Shih-Chang Lin
Journal:  Mol Med       Date:  2007 Nov-Dec       Impact factor: 6.354

7.  FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol.

Authors:  Rakesh K Srivastava; Terry G Unterman; Sharmila Shankar
Journal:  Mol Cell Biochem       Date:  2009-12-11       Impact factor: 3.396

8.  Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells.

Authors:  Shoukang Zhu; Sarah Evans; Bin Yan; Thomas J Povsic; Victor Tapson; Pascal J Goldschmidt-Clermont; Chunming Dong
Journal:  Circulation       Date:  2008-11-03       Impact factor: 29.690

9.  MicroRNA-25 contributes to cisplatin resistance in gastric cancer cells by inhibiting forkhead box O3a.

Authors:  Jingbo He; Huixiong Qi; Fang Chen; Chuanhua Cao
Journal:  Oncol Lett       Date:  2017-09-18       Impact factor: 2.967

10.  Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.

Authors:  Yiwei Li; Zhiwei Wang; Dejuan Kong; Ran Li; Sanila H Sarkar; Fazlul H Sarkar
Journal:  J Biol Chem       Date:  2008-08-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.